VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,684,000 | -89.0% | 26,400 | -80.7% | 0.83% | -86.9% |
| Q3 2015 | $24,354,000 | -30.6% | 136,528 | -13.6% | 6.36% | -16.0% |
| Q2 2015 | $35,110,000 | -2.4% | 158,045 | -12.7% | 7.57% | -7.6% |
| Q1 2015 | $35,959,000 | +59.0% | 181,045 | +14.5% | 8.19% | +11.9% |
| Q4 2014 | $22,619,000 | +73.1% | 158,050 | +58.7% | 7.32% | +55.8% |
| Q3 2014 | $13,068,000 | -18.4% | 99,600 | -21.6% | 4.70% | +4.2% |
| Q2 2014 | $16,017,000 | +5.7% | 127,000 | +10.4% | 4.50% | +13.8% |
| Q1 2014 | $15,160,000 | +23.0% | 115,000 | +9.5% | 3.96% | +50.0% |
| Q4 2013 | $12,327,000 | -15.1% | 105,000 | -24.6% | 2.64% | -27.3% |
| Q3 2013 | $14,522,000 | +415.5% | 139,190 | +325.3% | 3.63% | +583.6% |
| Q2 2013 | $2,817,000 | – | 32,724 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |